AKERS BIOSCIENCES INC - 00973E102

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2014 · Q1 2014
Value (USD)
Total reported value ($000)
$3.017M
QoQ value delta ($000)
-$136K (-4.31%)
Implied price effect (QoQ)
-2.24%
Shares
Total shares
676,961
QoQ shares delta
-14,659 (-2.12%)
Total shares held by funds (by quarter)

Top holders (Q2 2014)

Top 25 only Full list
Partial Q2 2014 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
COMMERZBANK AKTIENGESELLSCHAFT /FI 731 160,258 0.0%
LMR Partners LLP 574 136,342 0.05%
PERKINS CAPITAL MANAGEMENT INC 459 100,700 0.32%
BARD ASSOCIATES INC 410 90,000 0.17%
ROYAL BANK OF CANADA 298 65,284 0.0%
VANGUARD GROUP INC 254 60,354 0.0%
NOMURA HOLDINGS INC 123 26,962 0.0%
CITADEL ADVISORS LLC 59 13,023 0.0%
Trellus Management Company, LLC 53 11,556 0.05%
MORGAN STANLEY 23 5,007 0.0%
Tower Research Capital LLC 16 3,544 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 9 2,005 0.0%
UBS AG 5 1,194 0.0%
AMERICAN INTERNATIONAL GROUP INC 2 500 0.0%
CITIGROUP INC 1 232 0.0%